基本信息
views: 110
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Roland Wohlgemuth studied chemistry and biology at the University of Basel in Switzerland and obtained his Ph.D. at the Biocenter of the same university in 1979, working with Prof. Seelig on fundamental aspects of the structure and function of biological cell membranes. From 1980 to 1983 he did postdoctoral work on artificial photosynthesis with Prof. Melvin Calvin at the University of California in Berkeley and at the Lawrence Berkeley Laboratory with a Swiss National Science Foundation Award followed by a two-year employment by the US Department of Energy. Roland Wohlgemuth moved then back to Buchs in Switzerland, where from 1983 on he has lead and built up the program in basics for the life sciences, the biochemistry program and the bioanalytical and biochemistry/ biotechnology laboratories in the chemical company Fluka. He has further expanded there the biochemistry activities after Fluka became part in 1989 of the Sigma-Aldrich Corporation, which as a whole was itself acquired in 2015 by Merck KGaA. In 2017 Roland Wohlgemuth moved from industry to academia, working as Professor at Lodz University of Technology, where he is building up new research activities, teaching courses for bachelor, master and PhD students and involved in the creation of the new International Center for Research and Innovation on Biobased Materials. He is cofounder of the Swiss Industrial Biocatalysis Consortium, Chairman of ESAB, the European Society of Applied Biocatalysis, President of SKB, the Swiss Coordination Committee Biotechnology and Member of the Global STRENDA Commission. In addition, he serves as expert for National, European and International research programs, editorial boards of scientific journals, scientific committees and advisory boards. His research interests are at the molecular and engineering interface of medicine-biology-chemistry, in the areas of biocatalysis, glycobiology, metabolomics, protein analysis, bioanalytical technologies, molecular medicine, technical biochemistry, industrial biotechnology and bioeconomy.
Research Interests
Papers共 176 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Norman Hardt, Stefanie Kind,Roland Meier,Bernhard Schoenenberger,Thorsten Eggert,Markus Obkircher,Roland Wohlgemuth
Biocatalysis and Biotransformationpp.1-8, (2024)
LIFE-BASELno. 3 (2024): 364
Andrés R. Alcántara, Fahmi Ihza Alghiffary,Christiane Claassen,Gonzalo de Gonzalo, Eduardo Macedo de Melo,Rodrigo O.M.A. de Souza,Pablo Domínguez de María,William Finnigan,Antonio Franconetti,Daniela Gamenara,Nadia Guajardo,Selin Kara,
Biocatalysis in Asymmetric Synthesis (2024)
REACTION CHEMISTRY & ENGINEERINGno. 9 (2023): 2109-2118
Metabolitesno. 10 (2023): 1097-1097
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn